Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SR604 Prophylactic Treatment in Hemophilia A or B
NCT07876674Phase 3Not yet recruiting
- Sponsor
- Shanghai RAAS
- Start
- Sep 2026
- Primary completion
- Sep 2027
01
Overview
A Phase 3 trial of SR604 in hemophilia A, hemophilia B (HB), sponsored by Shanghai RAAS. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
SR604
03
Conditions
hemophilia Ahemophilia B (HB)
Beyond the preview
Go deeper on NCT07876674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07876674.